Lund Systemic Sclerosis Research Group
1 – 10 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
- Incidence and prevalence of systemic sclerosis globally : A comprehensive systematic review and meta-analysis
- Underfilling decreases left ventricular function in pulmonary arterial hypertension
- Longitudinal changes in risk status in pulmonary arterial hypertension
- Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
- An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
-
Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis
Mattsson, M. ; Sandqvist, G. LU
; Hesselstrand, R.
LU
; Olsson, D.
; Kwakkenbos, L.
; Nordin, A.
and Boström, C.
(2021)
In Scandinavian Journal of Rheumatology
Mark
- 2020
- Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy : a registry-based study
- Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
-
Successful lung transplantation in a patient with rheumatoid arthritis suffering from obliterative bronchiolitis
Bozovic, G. LU ; Larsson, H. LU ; Wuttge, D. M. LU ; Håkansson, M. LU ; Hansson, L. LU ; Ingemansson, R. LU ; Brunnström, H. LU
and Andréasson, K.
LU
(2020)
In Scandinavian Journal of Rheumatology
49(4).
p.334-335
Mark